Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 4, 2000, Pages 1107-1110

  Schlembach, Pamela J ^a   Wilder, Richard B ^a   Tucker, Susan L ^a   Ha, Chul S ^a   Rodriguez, Maria A ^a   Hess, Mark A ^a   Cabanillas, Fernando F ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Lymphoma; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOBLASTIC LYMPHADENOPATHY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VINCRISTINE;

EID: 0034333172     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00760-4     Document Type: Article

References (24)

1. Patterns of relapse in large-cell lymphoma patients with bulk disease; Implications for the use of adjuvant radiation therapy
2. Predictive model for prognosis in advanced diffuse histiocytic lymphoma
3. Treatment of aggressive non-Hodgkin's lymphoma
4. Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomas
5. New approaches to the management of patients with non-Hodgkin's lymphoma of high-grade pathology
6. Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas
7. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma
8. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'
9. Treatment of mycosis fungoides; Total-skin electron-beam irradiation vs topical mechlorethamine therapy
10. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
11. Nonparametric estimation from incomplete observations
12. Evaluation of survival data and two rank order statistics arising in its consideration
13. Regression model and life tables
14. Results of a salvage treatment program for relapsing lymphoma; MINE consolidated with ESHAP
15. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy
16. Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma
17. Bulk of tumour as an important prognostic factor in non-Hodgkin's lymphoma
18. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma
19. Diffuse large cell lymphoma. Prognostic factors with treatment
20. Prognostic factors in aggressive malignant lymphomas; Description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs
21. MACOP-B treatment in diffuse large-cell lymphoma; Identification of prognostic groups in an Italian multicenter study
22. Large-cell lymphoma; A study of prognostic factors and assessment of five recently proposed predictive systems